Medication-Assisted Treatment

Registration


The cost for this online course is $20. The estimated time to complete this on-demand course is 60 minutes. Learners will be asked to complete an activity post-assessment with a passing score of 75%.

Before enrolling in this educational activity, you must log in or create an account.

Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage.
 

Target Audience

Healthcare professionals.

Educational Need

Substance use disorders (SUDs), especially opioid use disorder (OUD), are major public health issues. Medication-assisted treatment (MAT), which combines medications with counseling, is highly effective but often underused due to stigma, lack of knowledge, and misunderstandings. Understanding MAT is key to improving access to effective care, enhancing recovery outcomes, and addressing the opioid crisis. 

Learning Objectives

  1. Define Medication-Assisted Treatment.
  2. Describe substance use disorders.
  3. Review medication treatment options related to substance use disorders within ambulatory and emergency settings.

Speaker

Andrea Storjohann, ARNP, PMHNP-CB, CADC, MSN
Prairie Ridge Behavioral Healthcare

Ms. Storjohann currently works for Prairie Ridge Behavioral Healthcare in Marshalltown, IA where she practices outpatient psychiatry and MAT. She has spent over a decade collaborating with stakeholders across Iowa, providing education, advocacy, and MAT/Behavioral Health program implementation assistance. Ms. Storjohann provides technical assistance to the Opioid Response Network and is a consultant for Sentinel University. She and her colleagues received the 2019 Addiction Policy Forum’s Innovation Award and have been featured in the New York Times and other news outlets.

Terms of Use and Privacy Policy

Recording date: October 17, 2024
Date of original release: October 17, 2024
Most recent review/update: October 17, 2024
Termination date: October 16, 2026

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credits™
  • 1.00 AOA Category 2­B
  • 1.00 CE Contact Hour(s)
  • 1.00 CPME
  • 1.00 IBON
Course opens: 
10/17/2024
Course expires: 
10/16/2026
Cost:
$20.00

Accreditation Statements

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University Medicine and Health Sciences (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • DPM: Des Moines University Medicine and Health Sciences (DMU) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. DMU has approved this activity for a maximum of 1.0 continuing education contact hours.
  • Nurse: Des Moines University Medicine and Health Sciences is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit is awarded.
  • Other healthcare providers: This activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 

Disclosures

The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

  • Andrea Storjohann, ARNP, PMHNP-CB, CADC, MSN - Speaker

Disclaimer

The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition. 

Available Credit

  • 1.00 AMA PRA Category 1 Credits™
  • 1.00 AOA Category 2­B
  • 1.00 CE Contact Hour(s)
  • 1.00 CPME
  • 1.00 IBON

Price

Cost:
$20.00
Please login or Create an Account to take this course.